Related Experiment Video
Updated: Jun 13, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Pleiotropic effects of statins. - Basic research and clinical perspectives -
1Vascular Medicine Research Unit, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02139, USA.
Summary
Statins offer cardiovascular benefits beyond lowering cholesterol, through pleiotropic effects like improved endothelial function and reduced inflammation. These effects stem from inhibiting isoprenoid synthesis, impacting key cellular signaling pathways.
Area of Science:
- Cardiovascular Science
- Pharmacology
Background:
- Statins (HMG-CoA reductase inhibitors) are primary treatments for hypercholesterolemia and cardiovascular disease prevention.
- Emerging evidence indicates statins possess cholesterol-independent, or pleiotropic, cardiovascular benefits.
Purpose of the Study:
- To review the non-cholesterol-dependent effects of statins on the cardiovascular system.
- To highlight recent research supporting the concept of statin pleiotropy from basic science to clinical application.
Main Methods:
- Review of experimental and clinical studies on statin pleiotropic effects.
- Focus on mechanisms involving isoprenoid synthesis inhibition and downstream signaling pathways (Rho, Rac, Cdc42, Rho kinase).
Main Results:
- Statins improve endothelial function, reduce vascular inflammation and oxidation, and stabilize atherosclerotic plaques.
- Inhibition of Rho and Rho kinase is a key mechanism for statin's pleiotropic actions.
Conclusions:
- Statins exert significant cardiovascular benefits independent of their lipid-lowering properties.
- Understanding statin pleiotropy offers new therapeutic insights for cardiovascular disease management.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...